Stock ITRM ITERUM THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

All News Iterum Therapeutics plc

Equities

ITRM

IE000TTOOBX0

Market Closed - Nasdaq
Other stock markets
 21:30:01 28/06/2024 BST 		5-day change 1st Jan Change
1.145 USD -4.58% Intraday chart for Iterum Therapeutics plc -7.66% -41.88%
06-21 Sector Update: Health Care Stocks Gain in Late Afternoon MT
06-21 Sector Update: Health Care MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Sector Update: Health Care Stocks Gain in Late Afternoon
MT
Sector Update: Health Care
MT
Iterum Therapeutics' New Drug Application for Sulopenem Referred to FDA Advisory Committee
MT
Iterum Therapeutics Announces FDA Advisory Committee Meeting to discuss NDA for Oral Sulopenem for the treatment of Uncomplicated Urinary Tract Infections
AQ
Iterum Therapeutics to Present Data at ASM Microbe 2024
AQ
Iterum Therapeutics Receives FDA Acceptance of Resubmission of NDA for Oral Sulopenem for the treatment of Uncomplicated Urinary Tract Infections
AQ
Iterum Therapeutics plc Receives FDA Acceptance of Resubmission of NDA for Oral Sulopenem for the treatment of Uncomplicated Urinary Tract Infections
CI
Transcript : Iterum Therapeutics plc, Q1 2024 Earnings Call, May 13, 2024
Iterum Therapeutics Reports First Quarter 2024 Financial Results
AQ
Iterum Therapeutics plc Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Iterum Therapeutics plc Announces Executive Changes
CI
Iterum Therapeutics to Report First Quarter 2024 Financial Results on May 13, 2024
AQ
Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem
AQ
Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem
CI
Transcript : Iterum Therapeutics plc, Q4 2023 Earnings Call, Mar 28, 2024
Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
AQ
Iterum Therapeutics plc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
AQ
Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat
AQ
Iterum Therapeutics Provides Business Update
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ITRM Stock
  4. News Iterum Therapeutics plc